What Is ASC (Aldehyde-Stabilized Cryopreservation) and Why We Prefer It

The Central Challenge of Brain Preservation

Cryonics has always had one fundamental goal: preserve the information content of the brain well enough that a future civilization could use it to restore you. Every debate about technique — vitrification, chemical fixation, cooling protocols — comes down to a single question: does the structure survive? At Saka Cryo, we believe Aldehyde-Stabilized Cryopreservation (ASC) answers that question more convincingly than any alternative currently available. And the reason has as much to do with resilience as it does with the quality of preservation itself.

What ASC Actually Does, Step by Step

ASC is a hybrid approach: part chemistry, part cryonics. The process begins immediately after legal death, when glutaraldehyde — a chemical fixative that has been used in laboratory tissue preservation for decades — is perfused through the brain's blood vessels. Within minutes, glutaraldehyde cross-links proteins throughout the tissue, locking every cell, every synapse, every dendritic spine in place. The brain becomes chemically fixed — biologically inert — at the fine synaptic level.

Once fixation is complete, the team slowly perfuses the brain with ethylene glycol, a cryoprotectant that prevents ice crystal formation. The brain is then cooled to -135°C and vitrified — held in a glass-like solid state for long-term storage.

The result is a brain preserved in extraordinary structural detail. Electron microscopy of ASC-preserved tissue shows the connectome — the full map of approximately 86 billion neurons and their trillions of connections — intact at the nanometer scale. This is the information that matters. This is what you are, in physical terms.

Why This Is Different from Traditional Vitrification

Traditional cryopreservation relies entirely on keeping the brain cold. Cryoprotectants are perfused into the tissue, and the brain is cooled past the glass transition point around -130°C — achieving vitrification — then brought to liquid nitrogen temperature at -196°C for long-term storage. If it stays there, ice crystals don't form and structure is preserved. But here is the critical caveat: it must stay there, continuously, without exception.

The vitrification process itself is also more difficult than it appears. The best available cryoprotectant solution, M22, must replace most of the water inside and outside the brain's cells to prevent ice formation. Doing so through an intact blood-brain barrier creates severe osmotic stress, shrinking the brain to roughly half its original volume — compressing the very structure you are trying to preserve.

Then there is the storage medium. Liquid nitrogen is not a simple refrigerant — it is a cryogen undergoing a constant phase transition from liquid to vapor. Managing that transition over decades or centuries introduces real engineering complexity. Liquid levels must be continuously monitored and replenished. Temperature gradients form between the liquid phase and the vapor phase above it, with vapor-phase temperatures documented as high as -72°C in some systems — well above the glass transition temperature where structural degradation begins. Liquid nitrogen is also not sterile: research in biobanking has shown it can harbor bacteria, fungi, and viable viruses that transfer between the medium and stored samples. None of these are unsolvable problems, but they are perpetual ones — dependencies that must be managed without interruption, indefinitely.

An ASC-preserved brain sidesteps all of this. Because the tissue is chemically fixed and biologically inert, it does not depend on continuous cryogenic conditions to maintain structural integrity. Pathogens in the storage medium are irrelevant. Temperature excursions that would threaten a traditionally vitrified brain are a non-event. The connectome is locked in place by glutaraldehyde cross-links that are stable across a wide temperature range — not by the thermometer reading.

The Black Swan Problem

In risk management, a "black swan" event is one that is rare, unpredictable, and potentially catastrophic. For a cryonics organization, black swans include: extended power outages from natural disasters, flooding that compromises cooling infrastructure, earthquakes, political instability, financial crises that interrupt operations, transportation emergencies during patient transfer.

Traditional vitrification demands that none of these events result in a significant temperature excursion — ever, for potentially hundreds of years. That is an extraordinarily demanding requirement. History suggests that over long enough timescales, disruptions of all kinds will occur. The question is whether your preservation method can absorb them.

ASC fundamentally changes the risk calculus. A power outage that lasts hours or even days does not compromise an ASC-preserved brain the way it could a traditionally vitrified one. This isn't a theoretical advantage — it is a concrete structural resilience that makes ASC a more defensible choice for indefinite storage across uncertain future conditions.

Picture two scenarios. In scenario one, a facility storing traditionally vitrified patients must evacuate on short notice — a wildfire is approaching, a region is destabilizing, a building is structurally compromised. Each patient is inside a dewar weighing several hundred kilograms filled with liquid nitrogen, a cryogen that poses asphyxiation risks in enclosed transport and requires specialized handling. Moving them requires heavy equipment, trained personnel, and a receiving facility with its own liquid nitrogen supply ready on arrival. Every hour of logistical delay is a hour closer to temperatures rising above the glass transition point. In scenario two, ASC-preserved patients face the same evacuation. Staff warm the tissue to ambient temperature, package the chemically fixed brains in standard protective containers, and transport them by any available vehicle. No cryogens, no specialized equipment, no race against boil-off. At the new facility, the brains are re-cooled at whatever pace conditions allow. The connectome is unchanged.

This is why Saka Cryo prefers ASC. Not because traditional vitrification is a bad technique — it isn't — but because ASC removes an entire category of existential risk.

Third-Party Validation: The Brain Preservation Foundation Prize

ASC is not an unproven approach. In 2016, the Brain Preservation Foundation (BPF) awarded its Small Mammal Brain Preservation Prize to the team behind ASC. The BPF prize was designed specifically to identify techniques that preserve the connectome with sufficient fidelity to be useful for revival. Judges evaluated the structural preservation of synapses, myelin sheaths, and fine neuronal architecture using electron microscopy.

ASC won. The preserved tissue showed ultrastructure — the fine detail at the nanometer scale — intact across the entire brain. This is independent, third-party scientific validation that ASC preserves what matters. It is not a marketing claim. It is a result that was published and peer-reviewed.

Addressing the Fixation Question

Some people raise a legitimate concern about ASC: because the tissue is chemically fixed, it is not biologically alive in any conventional sense. You cannot thaw an ASC-preserved brain and expect biological function to resume. Does this mean ASC is a dead end?

We don't think so — and here's why. The premise of cryonics revival has never been "thaw the brain and it wakes up." That's not how any serious cryonics researcher or revival theorist thinks about the problem. The actual path to revival runs through information: reading the connectome, understanding the precise pattern of neural connections, and using that information to reconstruct a functional mind.

If you accept that the brain's physical structure encodes the information that constitutes a person — and there is strong scientific reason to believe this — then a chemically fixed brain is not a dead end. It is a perfectly preserved record. Future technology capable of reading and reconstructing the connectome at atomic resolution would find an ASC-preserved brain to be an excellent substrate. The information is there. It is stable. It is not degrading.

The goal of cryonics has always been information preservation, not biological maintenance. ASC is simply honest about that goal from the start.

What This Means for You

At Saka Cryo, we support ASC and have plan to support traditional vitrification because we believe client choice matters and because both techniques, executed well, preserve meaningful structural information. But our institutional preference is clear: ASC's combination of high-fidelity connectome preservation and black-swan resilience makes it the more defensible long-term choice.

When you are planning for preservation that may need to last decades or centuries — through events none of us can predict — resilience is not a nice-to-have. It is a core requirement. ASC is the technique built for exactly that kind of indefinite, uncertain future.